利奈唑胺联合万古霉素对耐甲氧西林金黄色葡萄球菌生物被膜的干预作用

Intervention effect of linezolid combined with vancomycin on biofilms of methicillin-resistant Staphylococcus aureus

  • 摘要: 目的 探究利奈唑胺与万古霉素联用对临床分离耐甲氧西林金黄色葡萄球菌(MRSA)生物被膜的干预作用。方法 收集2020年1月-2021年1月武汉市第一医院临床分离MRSA菌株120株,测定利奈唑胺、万古霉素对MRSA的最低抑菌浓度(MIC)和分级抑菌浓度指数(FIC),绘制时间杀菌曲线,结晶紫染色法和扫描电镜观察评估对MRSA生物被膜的影响,实时荧光定量PCR(RT-qPCR)检测MRSA生物被膜相关基因(icaA、icaD、cidA、agrA和sarA)mRNA相对表达量。结果 利奈唑胺和万古霉素单用时MIC范围均0.5~2μg/ml,联用时MIC范围均为0.125~1μg/ml,且联用比单用时MIC、MIC50、MIC90均下降(P<0.05);两药联用以协同作用(73.33%)和相加作用(22.5%)为主,少数表现为无关作用(4.17%),无拮抗作用;利奈唑胺与万古霉素联用与单用在干预MRSA 24 h后均有较好抑菌效果;与单用利奈唑胺或万古霉素比较,联用时OD550降低(P<0.05),扫描电镜下可见MRSA生物膜形成被抑制;利奈唑胺与万古霉素单用或联用,MRSA被膜形成相关基因icaA、cidA、agrA和sarA mRNA相对表达量均下调(P<0.05),且联用作用强于单用(P<0.05)。结论 利奈唑胺与万古霉素具有协同或相加抑制MRSA作用,联用较单用效果更为显著,其作用机制可能与抑制MRSA被膜形成相关基因mRNA表达有关。

     

    Abstract: OBJECTIVE To explore the intervention effect of linezolid combined with vancomycin on biofilms of clinical methicillin-resistant Staphylococcus aureus(MRSA) isolates. METHODS Totally 120 strains of MRSA were isolated from Wuhan No.1 Hospital between Jan 2020 and Jan 2021. The minimum inhibitory concentrations(MICs) and fractional inhibitory concentrations(FICs) of vancomycin and linezolid against MRSA were determined, the time-killing curves were drawn, and the effects of linezolid and vancomycin alone and in combination on the biofilm of MRSA were observed by crystal violet staining method and electron microscope scanning. The relative expression levels of biofilm-related genes(icaA, icaD, cidA, agrA and sarA)mRNA in MRSA were detected by real-time fluorescent quantitative PCR(RT-qPCR). RESULTS The MICs of both linezolid and vancomycin ranged between 0.5 and 2 μg/ml, the MIC of linezolid combined with vancomycin ranged between 0.125 and 1 μg/ml, and the MIC, MIC50 and MIC90 of the combination of the two drugs were less than those of the single use(P<0.05). The synergistic effect(73.33%) and additive effect(22.5%) were dominant among the combination of the two drugs, few showed irrelevant effect(4.17%), and no antagonistic effect was observed. The combined and single use of linezolid and vancomycin showed remarkable antibacterial effect on MRSA after intervention for 24 hours; the OD550 of the combined use was lower than that of the single use(P<0.05). The formation of MRSA biofilms was inhibited, which could be seen under scanning electron microscopy. The relative expression levels of MRSA biofilm formation-related genes icaA, cidA, agrA and sarA mRNA were downregulated when the two drugs were used in combination or alone(P<0.05), and the effect of the combined use was greater than that of the single use(P<0.05). CONCLUSION Linezolid and vancomycin show synergistic or additive effect on inhibition of MRSA, the combination of the two drugs shows more remarkable effect, and the mechanisms may be associated with the expression of mRNA of genes that are related to inhibition of MRSA biofilms.

     

/

返回文章
返回